Article
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Author/s | Chacón López-Muñiz, J. I.
Cruz Merino, Luis de la Gavilá Gregori, J. Martínez Dueñas, E. Oliveira, M. Seguí Palmer, M. A. Álvarez López, I. Antolin Novoa, S. Bellet Ezquerra, M. López-Tarruella Cobo, S. |
Department | Universidad de Sevilla. Departamento de Medicina |
Publication Date | 2019 |
Deposit Date | 2024-03-08 |
Published in |
|
Abstract | Although the metastasic breast cancer is still an incurable disease, recent advances have increased signifcantly the time to
progression and the overall survival. However, too much information has been produced in the ... Although the metastasic breast cancer is still an incurable disease, recent advances have increased signifcantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference. |
Citation | Chacón López-Muñiz, J.I., Cruz Merino, L.d.l., Gavilá Gregori, J., Martínez Dueñas, E., Oliveira, M., Seguí Palmer, M.A.,...,López-Tarruella Cobo, S. (2019). SEOM clinical guidelines in advanced and recurrent breast cancer (2018). Clinical and Translational Oncology, 21 (1), 31-45. https://doi.org/10.1007/s12094-018-02010-w. |
Files | Size | Format | View | Description |
---|---|---|---|---|
SEOM clinical.pdf | 1.014Mb | [PDF] | View/ | |